Você está na página 1de 68

Perioperative Pearls, What Is

Necessary And What is


Appropriate

Saturday, 08 October 2011

M Chadi Alraies, MD FACP


Cleveland Clinic Foundation
Cleveland, Ohio, USA

Perioperative Pearls l Alraies l May 17, 2010


Disclosure

• None

Perioperative Pearls l Alraies l May 17, 2010


Overview
Medical consultant role perioperative care

 Nuts and bolts of the preop assessment


Preoperative risk stratification

 Cardiopulmonary risk
 Risk reducing interventions
Perioperative anticoagulation in patients on VKA or those with

coronary stents

Perioperative Pearls l Alraies l May 17, 2010


Scope of the problem

Perioperative Pearls l Alraies l May 17, 2010


Pathophysiology

Perioperative Pearls l Alraies l May 17, 2010


Surgery is Like a Plane Flight

Patient

Surgeon is the Anesthesia is


Pilot the Co-Pilot

Michota F, Jaffer A. Clev Clin J Med 2006

Perioperative Pearls l Alraies l May 17, 2010


Medical Consultant = Mechanic

 What is the condition of the


plane?
 Is the plane in the best condition
to fly?
 Under the best conditions, what
can the plane handle?
 Is the long-term maintenance
program adequate?

Perioperative Pearls l Alraies l May 17, 2010


Medical Consultant = Mechanic

Precise medical diagnoses


Evaluate the extent of organ disease


Optimize all medical conditions


Assess and describe physiologic limitations


Ensure adequate post-operative follow-up


Perioperative Pearls l Alraies l May 17, 2010


Medical Consultant Role

 Should not tell the pilot or the


co-pilot when or how to fly
 Do not CLEAR patients for
surgery “optimize”
 Should not make anesthetic
recommendations

Perioperative Pearls l Alraies l May 17, 2010


Preoperative Evaluation

Focus on the history


 Complete ROS, functional class, medications


Exam does not need to be comprehensive

Laboratory testing should be selective, not routine


Perioperative Pearls l Alraies l May 17, 2010


Perioperative Pearls l Alraies l May 17, 2010
Perioperative Cardiac
Risk Assessment

Perioperative Pearls l Alraies l May 17, 2010


Case 1

 A 75-yo presents preop for a radical prostatectomy for prostate cancer.


PMHx includes CAD with h/o 3V-CABG about 2 years ago, HTN and
Type 2 DM. His current meds include: insulin, atenolol, ASA. He is
very active swimming several laps for about 30 minutes at least 3
times per week; no CP but he does get SOB.

 Exam: P=68, BP=130/75, RR=18

 Lungs=CTA; heart exam is normal except for a paradoxical split S2; LE


pulses are normal.

Perioperative Pearls l Alraies l May 17, 2010


Question

According to the current ACC/AHA guidelines, is an


ECG recommended for this patient?


A.Yes
B.No

Perioperative Pearls l Alraies l May 17, 2010


Question

According to the current ACC/AHA guidelines, is an


ECG recommended for this patient?


A.Yes
B.No

EKG is normal sinus with left


anterior hemiblock

Perioperative Pearls l Alraies l May 17, 2010


What is the most appropriate next step in
regards to his cardiovascular risk?

A.Gated treadmill exercise test


B.Exercise thallium scintigraphy
C.Dobutamine echocardiography
D.Coronary angiography
E.No additional tests

Perioperative Pearls l Alraies l May 17, 2010


What is the most appropriate next step in
regards to his cardiovascular risk?

A.Gated treadmill exercise test


B.Exercise thallium scintigraphy
C.Dobutamine echocardiography
D.Coronary angiography
E.No additional tests

Perioperative Pearls l Alraies l May 17, 2010


ACC/AHA Guidelines
Preop ECG recommended

 Class I
 Vascular surgery patients with 1 risk factor*
Known CAD, PVD, CVD going for intermediate risk

surgery
Class IIa
Ischemic heart disease
Heart failure
 Vascular surgery Diabetes
Renal impairment
Class IIb
Cerebrovascular disease
 Intermediate risk surgery
 with 1 risk factor*

Fleisher LA et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


J Am Coll Cardiol. 2007 Oct 23;50(17):1707-32.

Perioperative Pearls l Alraies l May 17, 2010


Fleisher LA et al. J Am Coll Cardiol. 2007 Oct 23;50(17):1707-
32.

Perioperative
Perioperative Pearls Pearls
l Alraiesl May 17,17,
l May 2010
2010l
Factors Leading to Cumulative Risk for
Perioperative Cardiac Events

Fleisher LA et al. J Am Coll Cardiol. 2007 Oct 23;50(17):1707-


32.

Perioperative
Perioperative Pearls Pearls
l Alraiesl May 17,17,
l May 2010
2010l
Case 2

Perioperative
Perioperative Pearls Pearls
l Alraiesl May 17,17,
l May 2010
2010l
As the medical consultant, what is the MOST APPROPRIATE next
step?

1.Complete a full preoperative evaluation, including a


stress test, because she will need a vascular
procedure.
2.Ask the patient about her physical activity so you can
calculate her metabolic equivalents because she
will have an intermediate-risk surgery.
3.Evaluate her postoperatively for signs and symptoms
of a myocardial infarction (MI).
4.Ask for surgery to be delayed for 2 days until a β
blocker lowers her heart rate to between 55 and 65
bpm slowly.

Perioperative
Perioperative Pearls Pearls
l Alraiesl May 17,17,
l May 2010
2010l
Tailoring the Perioperative Evaluation
Based on the Urgency of Surgery

Perioperative
Perioperative Pearls Pearls
l Alraiesl May 17,17,
l May 2010
2010l
As the medical consultant, what is the MOST APPROPRIATE
next step?
1.Complete a full preoperative evaluation, including a
stress test, because she will need a vascular
procedure.
2.Ask the patient about her physical activity so you can
calculate her metabolic equivalents because she
will have an intermediate-risk surgery.
3.Evaluate her postoperatively for signs and symptoms
of a myocardial infarction (MI).
4.Ask for surgery to be delayed for 2 days until a β
blocker lowers her heart rate to between 55 and 65
bpm slowly.

Perioperative
Perioperative Pearls Pearls
l Alraiesl May 17,17,
l May 2010
2010l
Cardiovascular Risk Assessment

Is surgery emergent?
Yes Operating Room

Fleisher LA et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


Cardiovascular Risk Assessment

Is surgery emergent?
Yes Operating Room

No
Active cardiac condition?
Yes Evaluate and Treat
Cardiac condition

Fleisher LA et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


ACC/AHA Guidelines
Active cardiac conditions that require evaluation and
treatment before noncardiac surgery

Unstable coronary syndromes


Decompensated HF

Significant arrhythmias

 High grade AV block, Mobitz II AV block, 3rd degree


AV block, new VT, symptomatic bradycardia,
symptomatic VT, SVT with RVR
Severe valvular heart disease

Fleisher LA et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


Cardiovascular Risk Assessment

Is surgery emergent?
Yes Operating Room

No
Active cardiac condition?
Yes Evaluate and Treat
Cardiac condition

No
Low-risk surgery?

Fleisher LA et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


Cardiovascular Risk Assessment

Is surgery emergent?
Yes Operating Room

No
Active cardiac condition?
Yes Evaluate and Treat
Cardiac condition

No
Low-risk surgery?
Yes Operating Room

Fleisher LA et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


Cardiovascular Risk Assessment

Is surgery emergent?

No
Active cardiac condition?

No
Low-risk surgery?
Yes Operating Room

•Endoscopic procedures
•Superficial procedure
•Cataract
•Breast
Fleisher LA et al. JACC
2007

Perioperative Pearls l Alraies l May 17, 2010


Cardiovascular Risk Assessment

Is surgery emergent?
Yes Operating Room

No
Active cardiac condition?
Yes Evaluate and Treat
Cardiac condition

No
Low-risk surgery?
Yes Operating Room

No
Good (>4 METs) Yes Operating Room
Functional capacity?
Fleisher LA et al. JACC
2007
Perioperative Pearls l Alraies l May 17, 2010
Cardiovascular Risk Assessment

Is surgery emergent?

No Dress, toilet independently 1 METs


Walk indoors around the house 2 METs
Active cardiac condition? Light housework, vacuum, laundry 3 METs
Walk up a hill or a flight of stairs 4 METs
Golf, bowling, dancing 6 METs
No
Tennis, running, swimming, basketball 8 METs

Low-risk surgery?

No
Good (>4 METs) Yes Operating Room
Functional capacity?
Fleisher LA et al. JACC
2007
Perioperative Pearls l Alraies l May 17, 2010
Cardiovascular Risk Assessment
Good (>4 METs) Yes Operating Room
Functional capacity?
No

1-2 Risk No Risk


+3 Risk Factors
Factors Factors

Ischemic heart disease


Heart failure
Diabetes
Renal impairment
Cerebrovascular disease
High risk surgery

Fleisher LA et al. JACC


2007
Perioperative Pearls l Alraies l May 17, 2010
* Lee Cardiac Risk Index (RCRI)
Risk Category
 Event
Rate %
 Class I (0 pts) 0.5
 Class II (1 pt) 1.3
 Class III (2 pts) 3.6
 Class IV (>3 pts) 9.1

*Comprised of 6 factors: High-risk type surgery, ischemic heart


disease, h/o CHF, h/o Stroke, Diabetes on Insulin, Cr>2.0mg/dl

Lee et al. Circulation 1999;100:1043

Perioperative Pearls l Alraies l May 17, 2010


Procedure Related Stress
 High (Reported cardiac risk >5%)
Emergent major operations

Surgical Stress Level


Aortic/vascular surgery

Prolonged surgical procedures; large fluid shifts/blood loss

 Intermediate (Reported cardiac risk =1-5%)


Carotid endarterectomy
Head and neck Surgery

Intraperitoneal and intrathoracic Surgery

Orthopedic Surgery

Prostate Surgery (other than TURP)

 Low (Reported cardiac risk <1%)


Endoscopic procedures
Superficial procedure
Cataract

Breast

TURP (based on most studies, but not included by ACC/AHA)

Michota F, Frost S; Med Clin N Am


2002
Perioperative Pearls l Alraies l May 17, 2010
Cardiovascular Risk Assessment

Good (>4 METs) Yes Operating Room


Functional capacity?
No

1-2 Risk No Risk


+3 Risk Factors
Factors Factors

Yes
Vascular Intermediate Vascular
surgery Risk surgery surgery
Operating Room
Coronary
Assessment Operating Room with heart rate control or
noninvasive testing if it will change management
Fleisher LA et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


What is the role for beta blockers
and/or statins?
Depends on patient risk and type of surgery

 Vascular surgery patients benefit from both


 Intermediate risk patients do not benefit from
statins (DECREASE-IV)
 Data is conflicting on the role of beta-blockers in
intermediate risk patients (POISE vs.
DECREASE-IV)

Perioperative Pearls l Alraies l May 17, 2010


POISE vs. DECREASE IV

Both studies showed a reduction in CV events


POISE had excess strokes and overall mortality


Beta blocker doses and timing were different


 POISE (started just before surgery with maximum


therapeutic dose within 24 hours of surgery)

 DECREASE (started 30 days before surgery


using 12.5% of maximum therapeutic dose

Dunkelgrun M et al. Ann Surg 2009

Perioperative Pearls l Alraies l May 17, 2010


B
= Beta Blocker = Statin
B

Cardiovascular Risk Assessment


Good (>4 METs) Yes Operating Room
Functional capacity?
No

1-2 Risk No Risk


+3 Risk Factors
Factors Factors

Yes
Vascular Intermediate Vascular
B surgery Risk surgery B surgery
B B Operating Room
Coronary
Assessment Operating Room with heart rate control or
noninvasive testing if it will change management
Fleisher LA et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


B
= Beta Blocker
B

Cardiovascular Risk Assessment


Good (>4 METs) Yes Operating Room
Functional capacity?
No

1-2 Risk No Risk


+3 Risk Factors
Factors Factors

Yes
Intermediate
Risk surgery
>2 weeks <2 weeks
Operating Room
B preop preop
B
Operating Room with heart rate Noninvasive testing
control or noninvasive testing if it will change management
Michota FA. Ohio ACP 2009

Perioperative Pearls l Alraies l May 17, 2010


Case 3
 A 75-yo presents preop for a radical prostatectomy for prostate cancer.
PMHx includes CAD with h/o 2-vessel PTCA with DES stenting 8
months ago,
ago HTN and Type 2 DM. His current meds include: Insulin,
Atenolol, ASA, and clopidogrel.
clopidogrel He is very active swimming several
laps for about 30 minutes at least 3 times per week; no CP but he
does get SOB.

 Exam: P=68, BP=130/75, RR=18 Lungs=CTA; heart exam is normal


except for a paradoxical split S2; LE pulses are normal.

 EKG = NSR, LAHB

Perioperative Pearls l Alraies l May 17, 2010


Which of the following is the most
appropriate recommendation at this time?
A.Proceed to surgery on clopidogrel and aspirin

B.Discontinue clopidogrel and proceed to surgery on aspirin

C.Discontinue clopidogrel and aspirin and proceed to surgery now

D.Discontinue clopidogrel and aspirin and proceed to surgery with


a LMWH bridge

E.Discontinue clopidogrel and aspirin and proceed to surgery after


a four month delay

Perioperative Pearls l Alraies l May 17, 2010


Which of the following is the most
appropriate recommendation at this time?
A.Proceed to surgery on clopidogrel and aspirin

B.Discontinue clopidogrel and proceed to surgery on aspirin

C.Discontinue clopidogrel and aspirin and proceed to surgery now

D.Discontinue clopidogrel and aspirin and proceed to surgery with


a LMWH bridge

E.Discontinue clopidogrel and aspirin and proceed to surgery after


a four month delay

Perioperative Pearls l Alraies l May 17, 2010


ACC/AHA Guidelines
Previous
PCI

Balloon BMS DES

Time <14d >14d >30-45d <30-45d <365d >365d


since
PCI

Delay for elective Proceed to surgery Delay for elective Proceed to surgery
or nonurgent surgery on aspirin or nonurgent surgery on aspirin

Fleisher LA et al. JACC 2007


Grines CL et al. JACC 2007

Perioperative Pearls l Alraies l May 17, 2010


Case 4
 A 55 yo female with h/o COPD (last FEV1=2L ~ 1 yr ago) HTN, OA and
obesity presents for preop evaluation 2 weeks before TAH. She has
smoked 2ppd for the last 40yrs.

 Her meds include Ipratropium /albuterol inhaler (which she uses


sporadically), HCTZ, and acetaminophen. She denies SOB, or
cough.

 Exam: P=75, BP= 130/80, RR=18, SaO2=98%. Lungs=decreased air


entry bilaterally but no wheezing. Heart exam is normal. Extremities
are normal.

Perioperative Pearls l Alraies l May 17, 2010


What is the most appropriate next step in
regards to addressing her perioperative
pulmonary risk?

A.Preoperative spirometry

B.Re-education about daily inhaler use

C.Preoperative arterial blood gas (ABG)

D.Preoperative smoking cessation

E.Chest radiography

F.All of the above

Perioperative Pearls l Alraies l May 17, 2010


What is the most appropriate next step in
regards to addressing her perioperative
pulmonary risk?

A.Preoperative spirometry

B.Re-education about daily inhaler use

C.Preoperative arterial blood gas (ABG)

D.Preoperative smoking cessation

E.Chest radiography

F.All of the above

Perioperative Pearls l Alraies l May 17, 2010


Preoperative Spirometry
 No evidence for risk prediction perioperatively

 No threshold of values for which surgery is


contraindicated

 Consensus

 Lung Resection

 CABG

 Unexplained dyspnea or lung disease


ACP Guidelines for PFT’s. Ann Intern Med 1990;112:793-4

Qaseem A et al. Ann Intern Med 2006

Perioperative Pearls l Alraies l May 17, 2010


Risk factors for Postoperative
Pulmonary Complications
 Patient
 COPD
 Age>60 yrs
 ASA class > II
 Functional dependence
 CHF
 Albumin <3.5g/dL
 Procedure
 >3 hours duration, general anesthesia, emergency
surgery
 Thoracic, vascular, head and neck, neurosurgical,
Qaseem A et al. Ann Internand
Med 2006
abdominal procedures
Perioperative Pearls l Alraies l May 17, 2010
Risk factors for Postoperative
Pulmonary Complications
 Patient
 COPD Smoking data is mixed
 Age>60 yrs Obesity and mild
to moderate asthma are
 ASA class > II
not associated with
 Functional dependence increased risk
 CHF
 Albumin <3.5g/dL
 Procedure
 >3 hours duration, general anesthesia, emergency
surgery
 Thoracic, vascular, head and neck, neurosurgical,
Qaseem A et al. Ann Internand
Med 2006
abdominal procedures
Perioperative Pearls l Alraies l May 17, 2010
Preoperative Pulmonary
Risk-Reduction Strategies
Smoking cessation (>6-8 wks)

Reduce airway obstruction


 Strict adherence to prescribed medications

 Preoperative steroids as needed

Antibiotics for respiratory infection


Preoperative lung expansion education


 Incentive spirometry
Smetana GW et al. N Engl J Med 1999
Qaseem A et al. Ann Intern Med 2006

Perioperative Pearls l Alraies l May 17, 2010


Postop Pulmonary Risk-Reduction Strategies
 Good evidence of benefit
 Postoperative lung expansion modalities (A)
 Incentive spirometry, CPAP
 Selective postoperative nasogastric
decompression (B)
 Short-acting neuromuscular blockade (B)
 Equivocable evidence of benefit
 Laparoscopic (vs. open) operation (C)
 Conflicting evidence of benefit vs. harm
 Smoking cessation (I)
 Intraoperative neuraxial blockade (I)
 Postoperative epidural analgesia (I)
 Immunonutrition
Lawrence VA(I)
et al. Ann Int Med 2006
Perioperative Pearls l Alraies l May 17, 2010

Anticoagulation and Surgery

Perioperative Pearls l Alraies l May 17, 2010


Case 6
 72-year-old woman with history of rheumatic heart disease, atrial
fibrillation and s/p mechanical aortic valve is now scheduled for an
elective sigmoid resection for colon cancer.

 Patient is on warfarin with target INR 2.0-3.0.

Perioperative Pearls l Alraies l May 17, 2010


What are your recommendations for
perioperative anticoagulation?
A.Stop warfarin 5 days before surgery and resume warfarin on the morning of surgery

B.Stop warfarin 5 days before, use SC full dose LMWH starting 3 days before surgery;
resume full dose LMWH with warfarin post-operatively until the INR is
between 2 - 3

C.Use FFP and IV Vitamin K to reverse the effect of warfarin in the AM of surgery and
then proceed with surgery

D.Stop warfarin 5 days before, start IV UFH the same day; resume IV UFH with
warfarin post-operatively until the INR is between 2 - 3

7.

Perioperative Pearls l Alraies l May 17, 2010


What are your recommendations for
perioperative anticoagulation?
A.Stop warfarin 5 days before surgery and resume warfarin on the morning of surgery

B.Stop warfarin 5 days before, use SC full dose LMWH starting 3 days before surgery;
resume full dose LMWH with warfarin post-operatively until the INR is
between 2 - 3

C.Use FFP and IV Vitamin K to reverse the effect of warfarin in the AM of surgery and
then proceed with surgery

D.Stop warfarin 5 days before, start IV UFH the same day; resume IV UFH with
warfarin post-operatively until the INR is between 2 - 3

7.

Perioperative Pearls l Alraies l May 17, 2010


Thrombosis Risk “Window”
A therapeutic patient (INR 2-3) will generally need 5

days off OAC to lower the INR to this level


 Pre-procedural “window” of thrombosis risk

Therapeutic OAC will take another 3-4 days after the


procedure
 Post-procedural “window” of thrombosis risk

White RH et al. Arch Intern Med. 1995

Perioperative Pearls l Alraies l May 17, 2010


Who needs bridging therapy?

Perioperative Pearls l Alraies l May 17, 2010


No randomized controlled trials

Expert opinion

Perioperative
Perioperative
Pearls l Pearls
Alraies l l May
May17,
17,2010
2010 l
Anticoagulation and Surgery

Bleeding Thrombosis

surgery

Perioperative
Perioperative
Pearls l Pearls
Alraies l l May
May17,
17,2010
2010 l
Communication

 Consultant
 Surgeon
 Anesthesia
 Nursing staff

Perioperative
Perioperative
Pearls l Pearls
Alraies l l May
May17,
17,2010
2010 l
Thrombosis Risk “Window”

OAC stopped OAC started

Days -5 0 1 5

INR>2.0 INR<1.5 INR>2.0

INR INR
1.5-2.0 1.5-2.0

Procedure
Perioperative Pearls l Alraies l May 17, 2010
CHADS2 Score:
1.Recent CHF =1
2.Age ≥ 75 years
=1
3.Diabetes mellitus Kearon C et al. N Eng J Med 1997
=1 Gage J et al. JAMA 2001
4.Prior stroke or TIA
=2 Perioperative
Perioperative
Pearls l Pearls
Alraies l l May
May17,
17,2010
2010 l
UFH Bridge Protocol
OAC stopped OAC started

Days -5 0 1 5

INR>2.0 INR>2.0

Begin IVUFH Stop IVUFH


Stop IVUFH Begin IVUFH*
Procedure
1 Week LOS

Perioperative Pearls l Alraies l May 17, 2010


LMWH Bridge Protocol

OAC stopped OAC started

Days -5 0 1 5

INR>2.0 INR>2.0

Begin LMWH Stop LMWH


Stop LMWH* Begin LMWH*
Procedure
1-2 Day LOS

Perioperative Pearls l Alraies l May 17, 2010


Post-operative AC management consideration

• Close communication with surgeon and patient


• Monitor hemostasis, hematology and chemistry lab closely
• Start warfarin and prophylactic AC as soon as feasible
(within 24 hours)
• Avoid LMWH with impaired renal function (CrCl < 30 ml/min)
/ high risk bleeding surgery (neuro and cardiac)
• Full dose AC with 24 hours for moderate risk and 48-72 for
high risk for bleeding surgery.
• Fondaparinux is not recommended for bridging AC.

Perioperative
Perioperative Pearls Pearls
l Alraiesl May 17,17,
l May 2010
2010l
Thank you

Chadi Alraies, MD
Alraies@hotmail.com
www.chadialraies.blogspot.com

Perioperative Pearls l Alraies l May 17, 2010

Você também pode gostar